Thalidomide-O-PEG3-alcohol CAS:2286368-57-6 is a small molecule drug composed of several functional groups, including a thalidomide group, a polyethylene glycol (PEG) spacer, and an alcohol group. It is used in the treatment of certain types of cancer, such as multiple myeloma, as well as inflammatory diseases such as rheumatoid arthritis.
Thalidomide is a type of immunomodulatory drug that has been shown to be effective in treating cancer and inflammatory diseases. The PEG spacer in Thalidomide-O-PEG3-alcohol is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The alcohol group is important for the chemical reactivity and solubility of the compound.
In terms of its mechanism of action, Thalidomide-O-PEG3-alcohol works by modulating the activity of certain immune cells in the body, particularly T cells and natural killer cells. By enhancing the activity of these cells, Thalidomide-O-PEG3-alcohol can help to boost the body’s immune response to cancer cells and reduce inflammation, leading to improved outcomes for patients with cancer and inflammatory diseases.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.